Tech Company Financing Transactions
Alafair Biosciences Funding Round
Alafair Biosciences, based in Austin, received $2 million from ATP Fund and UT Horizon Fund.
Transaction Overview
Company Name
Announced On
8/11/2016
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Series A
Investors
ATP Fund (Lead Investor) (Kyle Cox)
Proceeds Purpose
This funding will support the launch of VersaWrap Tendon Protector and the development of our suite of VersaWrap products, developed to meet the needs of surgeons and their patients,' says Daniel Peterson, MD, Alafair's Chairman and CEO.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
6101 West Courtyard Dr. 2-225
Austin, TX 78730
USA
Austin, TX 78730
USA
Phone
Website
Email Address
Overview
Alafair Biosciences creates products that solve the post surgical tissue adhesion problem.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Brophy
Chief Operating Officer
John Joyoprayitno
VP - Finance
Bhushan Holay
VP - R & D
Vidhi Maheshwari
VP - Regulatory Affairs
Sarah Mayes
VP - Regulatory Affairs
Ben Walthall
VP - Sales
Alex Shaevitz
Browse more venture capital transactions:
Prev: 8/11/2016: AceBot.ai venture capital transaction
Next: 8/12/2016: Lua Technologies venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs